ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Kidney Week 2024: Exhibitor Spotlight Schedule

Thursday, October 24 - Saturday, October 26

San Diego Convention Center, Exhibit Hall A (Main Entrance at Hall B)

Join your colleagues for the latest advances in nephrology practices, products, services, and technologies presented in two theaters on the exhibit hall floor. Seating is limited and available on a first-come, first-served basis to fully registered Kidney Week participants only. Exhibitor Spotlights are not CE (continuing education) activities.

The 10:00 a.m. presentations include breakfast. All other presentations include lunch.

Thursday, October 24

10:00-10:45 a.m.
Helping Patients Go Home Successfully: The Home Dialysis Spotlight!
Presented by Baxter Healthcare Corporation

11:00-11:45 a.m.
Jardiance® (empagliflozin) tablets: Expert Perspectives on Clinical Trial Data and Approved Indications
Presented by Boehringer Ingelheim Pharmaceuticals, Inc./ Lilly USA

12:00-12:45 p.m.
A Stronger Foundation: Perspectives on an IgA Nephropathy Therapy with an Updated Indication
Presented by Travere Therapeutics

1:00-1:45 p.m.
Discover an Innovative Mechanism of Action: An Oral, Once-Daily HIF-PHI
Presented by Akebia Therapeutics

Friday, October 25

10:00-10:45 a.m.
Navigating IgA Nephropathy: Pathogenesis, the Role of APRIL, and Patient Case Study
Presented by Otsuka America Pharmaceutical, Inc.

11:00-11:45 a.m.
A Different Perspective on Hyperphosphatemia Management: Evaluating Current Strategies
Presented by Ardelyx, Inc.

12:00-12:45 p.m.
Get to Know FABHALTA® (iptacopan)
Presented by Novartis

1:00-1:45 p.m.
Early Intervention in IgA Nephropathy: An Update on a Potential Disease-Modifying Therapy
Presented by Calliditas Therapeutics

Saturday, October 26

10:00-10:45 a.m.
Transitions of Care in Kidney Transplant with ENVARSUS XR®
Presented by Veloxis Pharmaceuticals

11:00-11:45 a.m.
Effective Strategies with HIF PH Inhibitors: Insights from Real-World Evidence
Presented by Zydus Lifesciences

12:00-12:45 p.m.
Rare Disease Across the Lifespan: Helping Patients with Cystinosis Thrive into Adulthood
Presented by Amgen

1:00-1:45 p.m.
Potential Approaches to Addressing the Autoimmunity in Autoimmune Glomerulonephritis
Presented by Alpine Immune Sciences, a Vertex Company

*Additional information available by clicking on presentation title if provided by supporter.